Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte
Saved in:
Main Authors: |
Leon H. Baczkó István Sawicki G. Light P. E. Schulz R. |
---|---|
Format: | Article |
Published: |
2008
|
Series: | BRITISH JOURNAL OF PHARMACOLOGY
153 No. 4 |
doi: | 10.1038/sj.bjp.0707621 |
mtmt: | 1167398 |
Online Access: | http://publicatio.bibl.u-szeged.hu/16205 |
Similar Items
-
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes
by: Euler Gerhild, et al.
Published: (2021) -
Peroxynitrite - matrix metalloproteinase and erythropoietin receptor signaling pathways in ischemic heart disease
by: Kiss Krisztina
Published: (2017) -
Activation of PPARbeta/delta protects cardiac myocytes from oxidativestress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases
by: Eleftheria Barlaka, et al.
Published: (2015) -
Development of matrix metalloproteinase-2 inhibitors for cardioprotection
by: Bencsik Péter, et al.
Published: (2018) -
Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors
by: Gömöri Kamilla, et al.
Published: (2020)